US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 605.610
  • +15.610+2.65%
Close May 2 16:00 ET
  • 605.610
  • 0.0000.00%
Post 16:29 ET
65.38BMarket Cap15.39P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-20.63%8.35B
-16.90%9.01B
-16.90%9.01B
-1.18%9.8B
9.87%9.81B
17.41%10.52B
40.07%10.84B
40.07%10.84B
41.19%9.91B
17.99%8.93B
-Cash and cash equivalents
18.76%3.09B
-8.86%2.49B
-8.86%2.49B
-6.53%2.01B
-0.85%1.92B
-33.56%2.6B
-12.10%2.73B
-12.10%2.73B
-38.35%2.15B
-42.94%1.94B
-Short-term investments
-33.57%5.26B
-19.60%6.52B
-19.60%6.52B
0.30%7.78B
12.84%7.89B
56.99%7.92B
75.02%8.11B
75.02%8.11B
119.84%7.76B
67.59%6.99B
Receivables
6.49%5.56B
9.61%6.21B
9.61%6.21B
9.36%6.11B
11.63%5.72B
2.02%5.22B
6.35%5.67B
6.35%5.67B
0.65%5.58B
-0.78%5.12B
-Accounts receivable
6.49%5.56B
9.61%6.21B
9.61%6.21B
9.36%6.11B
11.63%5.72B
2.02%5.22B
6.35%5.67B
6.35%5.67B
0.65%5.58B
-0.78%5.12B
Inventory
17.59%3.19B
19.64%3.09B
19.64%3.09B
17.80%3.02B
14.59%2.87B
11.97%2.71B
7.44%2.58B
7.44%2.58B
6.21%2.56B
13.04%2.51B
Restricted cash
----
----
----
----
----
----
----
----
----
--5.5M
Other current assets
13.02%468.9M
-9.67%349.2M
-9.67%349.2M
-28.31%412M
89.00%681.9M
2.14%414.9M
-5.98%386.6M
-5.98%386.6M
28.74%574.7M
-38.18%360.8M
Total current assets
-6.89%17.57B
-4.20%18.66B
-4.20%18.66B
3.75%19.33B
12.76%19.08B
11.60%18.87B
22.63%19.48B
22.63%19.48B
20.78%18.63B
8.97%16.92B
Non current assets
Net PPE
11.09%4.69B
10.93%4.6B
10.93%4.6B
10.81%4.44B
9.77%4.31B
8.88%4.23B
10.19%4.15B
10.19%4.15B
8.15%4.01B
7.83%3.92B
-Gross PPE
----
12.43%6.89B
12.43%6.89B
----
----
----
12.76%6.13B
12.76%6.13B
----
----
-Accumulated depreciation
----
-15.57%-2.29B
-15.57%-2.29B
----
----
----
-18.55%-1.98B
-18.55%-1.98B
----
----
Goodwill and other intangible assets
10.23%1.17B
10.59%1.15B
10.59%1.15B
10.12%1.12B
15.66%1.1B
14.00%1.06B
13.45%1.04B
13.45%1.04B
26.50%1.02B
--953M
-Other intangible assets
----
10.59%1.15B
10.59%1.15B
----
----
----
13.45%1.04B
13.45%1.04B
----
----
Investments and advances
32.92%9.28B
64.92%8.9B
64.92%8.9B
46.94%8.49B
22.05%7.72B
15.04%6.98B
-18.13%5.4B
-18.13%5.4B
-3.19%5.78B
-1.38%6.33B
Non current deferred assets
24.52%3.44B
28.68%3.31B
28.68%3.31B
30.14%3.02B
34.72%2.88B
43.64%2.76B
49.41%2.58B
49.41%2.58B
59.55%2.32B
58.13%2.14B
Other non current assets
196.28%1.39B
155.80%1.14B
155.80%1.14B
154.45%1.04B
152.75%993.8M
34.50%470.2M
32.02%444.1M
32.02%444.1M
28.01%409.9M
45.68%393.2M
Total non current assets
28.88%19.97B
40.42%19.1B
40.42%19.1B
33.85%18.11B
23.81%17.01B
17.85%15.5B
2.03%13.6B
2.03%13.6B
10.44%13.53B
17.63%13.73B
Total assets
9.24%37.55B
14.15%37.76B
14.15%37.76B
16.41%37.44B
17.71%36.09B
14.34%34.37B
13.23%33.08B
13.23%33.08B
16.21%32.16B
12.69%30.66B
Liabilities
Current liabilities
Payables
5.09%705.5M
62.17%1B
62.17%1B
-7.32%497.3M
2.63%561.7M
11.98%671.3M
4.94%618.3M
4.94%618.3M
0.19%536.6M
2.45%547.3M
-accounts payable
5.09%705.5M
30.15%789.5M
30.15%789.5M
-7.32%497.3M
2.63%561.7M
11.98%671.3M
2.95%606.6M
2.95%606.6M
0.19%536.6M
2.45%547.3M
-Total tax payable
----
1,722.22%213.2M
1,722.22%213.2M
----
----
----
--11.7M
--11.7M
----
----
Current accrued expenses
-6.31%2.24B
-1.38%2.31B
-1.38%2.31B
-4.09%2.54B
8.50%2.36B
15.36%2.39B
13.11%2.35B
13.11%2.35B
47.22%2.64B
12.55%2.18B
Current deferred liabilities
19.86%619.3M
36.78%627.7M
36.78%627.7M
50.30%627.2M
53.77%586M
21.21%516.7M
-3.98%458.9M
-3.98%458.9M
-23.74%417.3M
-32.70%381.1M
Current liabilities
-0.40%3.57B
15.22%3.94B
15.22%3.94B
1.73%3.66B
13.02%3.51B
15.51%3.58B
8.98%3.42B
8.98%3.42B
24.99%3.6B
2.32%3.1B
Non current liabilities
Long term debt and capital lease obligation
0.06%2.7B
0.06%2.7B
0.06%2.7B
0.05%2.7B
0.05%2.7B
0.06%2.7B
0.06%2.7B
0.06%2.7B
0.06%2.7B
0.06%2.7B
-Long term debt
0.08%1.98B
0.08%1.98B
0.08%1.98B
0.07%1.98B
0.07%1.98B
0.08%1.98B
0.08%1.98B
0.08%1.98B
0.08%1.98B
0.08%1.98B
-Long term capital lease obligation
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
Non current deferred liabilities
13.99%211.8M
46.57%185.7M
46.57%185.7M
65.52%207.4M
76.94%205.6M
117.31%185.8M
81.52%126.7M
81.52%126.7M
108.49%125.3M
97.96%116.2M
Other non current liabilities
84.30%1.67B
83.98%1.57B
83.98%1.57B
85.44%1.54B
104.13%1.46B
34.14%908.5M
33.87%854.1M
33.87%854.1M
39.06%832.4M
-1.09%716.8M
Total non current liabilities
20.89%4.59B
21.11%4.46B
21.11%4.46B
21.71%4.46B
23.68%4.37B
9.61%3.8B
8.05%3.68B
8.05%3.68B
8.94%3.66B
1.47%3.54B
Total liabilities
10.56%8.16B
18.27%8.41B
18.27%8.41B
11.81%8.12B
18.70%7.88B
12.40%7.38B
8.50%7.11B
8.50%7.11B
16.35%7.26B
1.87%6.64B
Shareholders'equity
Share capital
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
-common stock
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
15.73%32.38B
16.19%31.67B
16.19%31.67B
17.83%30.76B
17.22%29.41B
15.99%27.98B
16.96%27.26B
16.96%27.26B
18.05%26.1B
20.67%25.09B
Paid-in capital
10.46%13.19B
13.23%12.86B
13.23%12.86B
12.90%12.7B
13.12%12.32B
12.69%11.94B
14.12%11.35B
14.12%11.35B
18.21%11.25B
19.39%10.89B
Less: Treasury stock
26.15%16.22B
20.76%15.17B
20.76%15.17B
15.66%14.19B
14.36%13.46B
16.40%12.86B
21.32%12.56B
21.32%12.56B
23.78%12.27B
30.69%11.77B
Gains losses not affecting retained earnings
137.69%29.1M
90.23%-7.9M
90.23%-7.9M
134.05%60.2M
64.64%-69.9M
57.49%-77.2M
66.12%-80.9M
66.12%-80.9M
35.73%-176.8M
11.66%-197.7M
Total stockholders'equity
8.88%29.39B
13.02%29.35B
13.02%29.35B
17.75%29.33B
17.44%28.21B
14.88%26.99B
14.60%25.97B
14.60%25.97B
16.17%24.9B
16.10%24.02B
Total equity
8.88%29.39B
13.02%29.35B
13.02%29.35B
17.75%29.33B
17.44%28.21B
14.88%26.99B
14.60%25.97B
14.60%25.97B
16.17%24.9B
16.10%24.02B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -20.63%8.35B-16.90%9.01B-16.90%9.01B-1.18%9.8B9.87%9.81B17.41%10.52B40.07%10.84B40.07%10.84B41.19%9.91B17.99%8.93B
-Cash and cash equivalents 18.76%3.09B-8.86%2.49B-8.86%2.49B-6.53%2.01B-0.85%1.92B-33.56%2.6B-12.10%2.73B-12.10%2.73B-38.35%2.15B-42.94%1.94B
-Short-term investments -33.57%5.26B-19.60%6.52B-19.60%6.52B0.30%7.78B12.84%7.89B56.99%7.92B75.02%8.11B75.02%8.11B119.84%7.76B67.59%6.99B
Receivables 6.49%5.56B9.61%6.21B9.61%6.21B9.36%6.11B11.63%5.72B2.02%5.22B6.35%5.67B6.35%5.67B0.65%5.58B-0.78%5.12B
-Accounts receivable 6.49%5.56B9.61%6.21B9.61%6.21B9.36%6.11B11.63%5.72B2.02%5.22B6.35%5.67B6.35%5.67B0.65%5.58B-0.78%5.12B
Inventory 17.59%3.19B19.64%3.09B19.64%3.09B17.80%3.02B14.59%2.87B11.97%2.71B7.44%2.58B7.44%2.58B6.21%2.56B13.04%2.51B
Restricted cash --------------------------------------5.5M
Other current assets 13.02%468.9M-9.67%349.2M-9.67%349.2M-28.31%412M89.00%681.9M2.14%414.9M-5.98%386.6M-5.98%386.6M28.74%574.7M-38.18%360.8M
Total current assets -6.89%17.57B-4.20%18.66B-4.20%18.66B3.75%19.33B12.76%19.08B11.60%18.87B22.63%19.48B22.63%19.48B20.78%18.63B8.97%16.92B
Non current assets
Net PPE 11.09%4.69B10.93%4.6B10.93%4.6B10.81%4.44B9.77%4.31B8.88%4.23B10.19%4.15B10.19%4.15B8.15%4.01B7.83%3.92B
-Gross PPE ----12.43%6.89B12.43%6.89B------------12.76%6.13B12.76%6.13B--------
-Accumulated depreciation -----15.57%-2.29B-15.57%-2.29B-------------18.55%-1.98B-18.55%-1.98B--------
Goodwill and other intangible assets 10.23%1.17B10.59%1.15B10.59%1.15B10.12%1.12B15.66%1.1B14.00%1.06B13.45%1.04B13.45%1.04B26.50%1.02B--953M
-Other intangible assets ----10.59%1.15B10.59%1.15B------------13.45%1.04B13.45%1.04B--------
Investments and advances 32.92%9.28B64.92%8.9B64.92%8.9B46.94%8.49B22.05%7.72B15.04%6.98B-18.13%5.4B-18.13%5.4B-3.19%5.78B-1.38%6.33B
Non current deferred assets 24.52%3.44B28.68%3.31B28.68%3.31B30.14%3.02B34.72%2.88B43.64%2.76B49.41%2.58B49.41%2.58B59.55%2.32B58.13%2.14B
Other non current assets 196.28%1.39B155.80%1.14B155.80%1.14B154.45%1.04B152.75%993.8M34.50%470.2M32.02%444.1M32.02%444.1M28.01%409.9M45.68%393.2M
Total non current assets 28.88%19.97B40.42%19.1B40.42%19.1B33.85%18.11B23.81%17.01B17.85%15.5B2.03%13.6B2.03%13.6B10.44%13.53B17.63%13.73B
Total assets 9.24%37.55B14.15%37.76B14.15%37.76B16.41%37.44B17.71%36.09B14.34%34.37B13.23%33.08B13.23%33.08B16.21%32.16B12.69%30.66B
Liabilities
Current liabilities
Payables 5.09%705.5M62.17%1B62.17%1B-7.32%497.3M2.63%561.7M11.98%671.3M4.94%618.3M4.94%618.3M0.19%536.6M2.45%547.3M
-accounts payable 5.09%705.5M30.15%789.5M30.15%789.5M-7.32%497.3M2.63%561.7M11.98%671.3M2.95%606.6M2.95%606.6M0.19%536.6M2.45%547.3M
-Total tax payable ----1,722.22%213.2M1,722.22%213.2M--------------11.7M--11.7M--------
Current accrued expenses -6.31%2.24B-1.38%2.31B-1.38%2.31B-4.09%2.54B8.50%2.36B15.36%2.39B13.11%2.35B13.11%2.35B47.22%2.64B12.55%2.18B
Current deferred liabilities 19.86%619.3M36.78%627.7M36.78%627.7M50.30%627.2M53.77%586M21.21%516.7M-3.98%458.9M-3.98%458.9M-23.74%417.3M-32.70%381.1M
Current liabilities -0.40%3.57B15.22%3.94B15.22%3.94B1.73%3.66B13.02%3.51B15.51%3.58B8.98%3.42B8.98%3.42B24.99%3.6B2.32%3.1B
Non current liabilities
Long term debt and capital lease obligation 0.06%2.7B0.06%2.7B0.06%2.7B0.05%2.7B0.05%2.7B0.06%2.7B0.06%2.7B0.06%2.7B0.06%2.7B0.06%2.7B
-Long term debt 0.08%1.98B0.08%1.98B0.08%1.98B0.07%1.98B0.07%1.98B0.08%1.98B0.08%1.98B0.08%1.98B0.08%1.98B0.08%1.98B
-Long term capital lease obligation 0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M
Non current deferred liabilities 13.99%211.8M46.57%185.7M46.57%185.7M65.52%207.4M76.94%205.6M117.31%185.8M81.52%126.7M81.52%126.7M108.49%125.3M97.96%116.2M
Other non current liabilities 84.30%1.67B83.98%1.57B83.98%1.57B85.44%1.54B104.13%1.46B34.14%908.5M33.87%854.1M33.87%854.1M39.06%832.4M-1.09%716.8M
Total non current liabilities 20.89%4.59B21.11%4.46B21.11%4.46B21.71%4.46B23.68%4.37B9.61%3.8B8.05%3.68B8.05%3.68B8.94%3.66B1.47%3.54B
Total liabilities 10.56%8.16B18.27%8.41B18.27%8.41B11.81%8.12B18.70%7.88B12.40%7.38B8.50%7.11B8.50%7.11B16.35%7.26B1.87%6.64B
Shareholders'equity
Share capital 0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K
-common stock 0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings 15.73%32.38B16.19%31.67B16.19%31.67B17.83%30.76B17.22%29.41B15.99%27.98B16.96%27.26B16.96%27.26B18.05%26.1B20.67%25.09B
Paid-in capital 10.46%13.19B13.23%12.86B13.23%12.86B12.90%12.7B13.12%12.32B12.69%11.94B14.12%11.35B14.12%11.35B18.21%11.25B19.39%10.89B
Less: Treasury stock 26.15%16.22B20.76%15.17B20.76%15.17B15.66%14.19B14.36%13.46B16.40%12.86B21.32%12.56B21.32%12.56B23.78%12.27B30.69%11.77B
Gains losses not affecting retained earnings 137.69%29.1M90.23%-7.9M90.23%-7.9M134.05%60.2M64.64%-69.9M57.49%-77.2M66.12%-80.9M66.12%-80.9M35.73%-176.8M11.66%-197.7M
Total stockholders'equity 8.88%29.39B13.02%29.35B13.02%29.35B17.75%29.33B17.44%28.21B14.88%26.99B14.60%25.97B14.60%25.97B16.17%24.9B16.10%24.02B
Total equity 8.88%29.39B13.02%29.35B13.02%29.35B17.75%29.33B17.44%28.21B14.88%26.99B14.60%25.97B14.60%25.97B16.17%24.9B16.10%24.02B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Meta Platforms
META
597.020
Oracle
ORCL
150.730
Strategy
MSTR
394.370
4
Toll Brothers
TOL
104.330
5
MARA Holdings
MARA
14.480
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.